↓ Skip to main content

Acupuncture for acute moderate thalamic hemorrhage: randomized controlled trial study protocol

Overview of attention for article published in BMC Complementary Medicine and Therapies, February 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Acupuncture for acute moderate thalamic hemorrhage: randomized controlled trial study protocol
Published in
BMC Complementary Medicine and Therapies, February 2017
DOI 10.1186/s12906-017-1614-6
Pubmed ID
Authors

Chengwei Wang, Chao You, Lu Ma, Mengyue Liu, Meng Tian, Ning Li

Abstract

Thalamic hemorrhage (TH) is a neurological insult with a high rate of morbidity and mortality. Moderate TH (10-30 ml) accounts for more than half of all TH. Treatment remains controversial. The role of acupuncture in patients with moderate TH is not clear. We will conduct a single-center, randomized, parallel group, and assessor-blinded clinical trial. A total of 488 patients with moderate TH will be randomly assigned to one of eight groups: 10-15 cc left sided TH study group (N = 61) and a corresponding control group (N = 61), 10-15 cc right sided TH study group (N = 61) and a corresponding control group, 15-30 cc left sided TH study group (N = 61) and a corresponding control group (N = 61), and 15-30 cc right sided TH study group (N = 61) and a corresponding control group. Study groups will receive acupuncture in addition to standard treatment, while control groups will receive standard treatment alone. The primary outcome will be change in National Institutes of Health Stroke Scale scores at 30 and 90 days after TH. The secondary outcomes will be death or major disability, defined as a score of 3 to 6 on the modified Rankin scale (in which a score of 0 indicates no symptoms, a score of 5 indicates severe disability, and a score of 6 indicates death) at 90-days, need for surgery at 30-days, Glasgow Outcome Scale (GOS) score at 90-days following TH onset, and the results of several additional group specific tests. The rate of adverse events will then be compared between the groups. This study will attempt to answer the question of whether or not acupuncture can improve neurologic outcome following moderate TH.  TRIAL REGISTRATION: Chinese clinical trial registry (ChiCTR-IOR-16008362).

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 56 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 16%
Student > Bachelor 5 9%
Student > Master 4 7%
Other 3 5%
Student > Postgraduate 3 5%
Other 6 11%
Unknown 26 46%
Readers by discipline Count As %
Medicine and Dentistry 14 25%
Nursing and Health Professions 5 9%
Neuroscience 5 9%
Chemistry 2 4%
Economics, Econometrics and Finance 1 2%
Other 3 5%
Unknown 26 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 February 2019.
All research outputs
#2,963,288
of 22,955,959 outputs
Outputs from BMC Complementary Medicine and Therapies
#561
of 3,639 outputs
Outputs of similar age
#70,501
of 454,401 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#15
of 101 outputs
Altmetric has tracked 22,955,959 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,639 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,401 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.